Ozempic is approved for type 2 diabetes with a maximum dose of 2 mg weekly
However, it does not necessarily follow that the lowest possible homocysteine concentration is always the optimal goal
These findings hint at a much broader therapeutic future for these medications, potentially offering relief for millions beyond the diabetic population
What the GLP-1 Bone Loss Research Means for Women Over 40 Specifically The research on GLP-1 therapy and bone loss is generating particular clinical attention in the context of women over 40 - and specifically women in perimenopause and menopause - because this population already faces a well-documented accelerated rate of bone density loss driven by estrogen decline
West, S., Scragg, J., Aveyard, P., Oke, J
Younger-Looking Skin & Hair Restoration Peptides such as GHK-Cu stimulate collagen and elastin production, improving elasticity, reducing fine lines, and even promoting healthy hair growth